2 ms·

I like the example of the MI and stroke reducing polypill. However, if the only reason why this pill's not sold is because it delivers a low return on investmen

by ucha 11y ago

I like the example of the MI and stroke reducing polypill. However, if the only reason why this pill's not sold is because it delivers a low return on investment due to the high cost of the clinical trials, why aren't countries where medical research is less privatized stepping in? Surely, this miracle pill would be tested and ultimately sold in Cuba and some European countries with excellent medical facilities where the public sector shares a larger part in healthcare costs. What's preventing this?

ams6110 11y ago
Um, the high cost of the clinical trials is not due to privatized medical research. the cost of the large clinical trials required for FDA approval It is FDA regulations, not privatized medical R&D.
- ucha 11y ago
  I didn't say that the cost was high because of private medical search. Only that a private pharmaceutical company will not want to have negative returns regardless of the origin of the costs.
  - a3n 11y ago
    Yes, a public good, which a country can decide to acquire and provide or not.